INAB Latest Press Releases

-- July 9, 2026 --

IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma Globe Newswire 8:00 AM

-- June 3, 2026 --

IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies Globe Newswire 8:30 AM

-- June 1, 2026 --

IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026 Globe Newswire 8:30 AM

-- May 14, 2026 --

IN8bio Presents New Translational Data Demonstrating DeltEx DRI Reshapes the Immune Landscape in Glioblastoma Globe Newswire 8:00 AM

-- May 7, 2026 --

IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights Globe Newswire 4:30 PM

-- May 6, 2026 --

IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences Globe Newswire 8:00 AM

-- April 3, 2026 --

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:00 PM

-- March 12, 2026 --

IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results - Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026 Globe Newswire 4:01 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software